CYP3A4 and metabolic dysfunction-associated steatotic liver disease: NSAH is itself a risk factor for liver dysfunction [41], and further study is needed to investigate the relationship of obesity-associated factors such as CYP3A4 or NAFLD/NASH with hepatotoxicity.